Allometric dose retranslation unveiled substantial immunological side effects of granulocyte colony-stimulating factor after stroke

Stroke

Volumn 45, Issue 2, 2014, Pages 623-626

  Wagner, Daniel Christoph ^a,b   Pösel, Claudia ^a   Schulz, Isabell ^a   Schicht, Gerda ^a   Boltze, Johannes ^a,b,c   Lange, Franziska ^a   Scheibe, Johanna ^a   Möller, Karoline ^a   Weise, Gesa ^a,b  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Granulocyte colony stimulating factor; Immune system; Stroke

Indexed keywords

GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNE SYSTEM; STROKE;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNOMODULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; PERIPHERAL NERVES; SPLEEN; STROKE; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 84893756004     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.003812     Document Type: Article

References (12)

1. Minnerup J, Heidrich J, Wellmann J, Rogalewski A, Schneider A, Schäbitz WR. Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke. 2008;39:1855-1861.
2. Ringelstein EB, Thijs V, Norrving B, Chamorro A, Aichner F, Grond M, et al; AXIS 2 Investigators. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke. 2013;44:2681-2687.
3. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659-661.
4. Hermann DM, Kilic E. Therapeutic potential and possible risks of pleiotropic growth factors in ischemic stroke. Stroke. 2008;39:e182; author reply e183.
5. Rutella S, Zavala F, Danese S, Kared H, Leone G. Granulocyte colony- stimulating factor: a novel mediator of T cell tolerance. J Immunol. 2005;175:7085-7091.
6. del Hoyo GM, Martín P, Vargas HH, Ruiz S, Arias CF, Ardavín C. Characterization of a common precursor population for dendritic cells. Nature. 2002;415:1043-1047.
7. Kleinschnitz C, Kraft P, Dreykluft A, Hagedorn I, Göbel K, Schuhmann MK, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121:679-691.
8. Gu L, Xiong X, Zhang H, Xu B, Steinberg GK, Zhao H. Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke. 2012;43:1941-1946.
9. Saito M, Kiyokawa N, Taguchi T, Suzuki K, Sekino T, Mimori K, et al. Granulocyte colony-stimulating factor directly affects human monocytes and modulates cytokine secretion. Exp Hematol. 2002;30:1115-1123.
10. Vuckovic S, Kim M, Khalil D, Turtle CJ, Crosbie GV, Williams N, et al. Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood. 2003;101:2314-2317.
11. Gliem M, Mausberg AK, Lee JI, Simiantonakis I, van Rooijen N, Hartung HP, et al. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol. 2012;71:743-752.
12. Doyle KP, Buckwalter MS. The double-edged sword of inflammation after stroke: what sharpens each edge? Ann Neurol. 2012;71:729-731.